DB
Dan Brennan TD Cowen Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Adaptive Biotechnologies
ADPT
$1.98B
| $13.02 | $15 |
15%
upside
| Buy | 29 days ago |
|
|
CAI
2
Caris Life Sciences, Inc. Common Stock
CAI
$10.2B
| $36.35 | $32 |
12%
downside
| Buy | 1 month ago |
|
3
Guardant Health
GH
$7.65B
| $61.36 | $60 |
2%
downside
| Buy | 4 months ago |
|
4
GeneDx Holdings
WGS
$3.74B
| $130.26 | $110 |
16%
downside
| Buy | 4 months ago |
|
5
Maravai LifeSciences
MRVI
$341M
| $2.36 | $2.50 |
6%
upside
| Neutral | 5 months ago |
|
|
TEM
6
Tempus AI, Inc. Class A Common Stock
TEM
$13.6B
| $78.12 | $74 |
5%
downside
| Buy | 7 months ago |
|
|
7
GeneDx Holdings
WGS
$3.74B
| $130.26 | $118 |
9%
downside
| Buy | 8 months ago |
|
8
Exact Sciences
EXAS
$9.73B
| $51.41 | $86 |
67%
upside
| Buy | 9 months ago |
|
9
Natera
NTRA
$22.9B
| $166.56 | $175 |
5%
upside
| Buy | 9 months ago |
|
10
Charles River Laboratories
CRL
$7.99B
| $162.31 | $250 |
54%
upside
| Buy | 10 months ago |
|
11
Bruker
BRKR
$4.52B
| $29.79 | $70 |
135%
upside
| Hold | 10 months ago |
|
12
Illumina
ILMN
$15.5B
| $97.68 | $177 |
81%
upside
| Buy | 10 months ago |
|
13
Revvity
RVTY
$9.95B
| $85.70 | $144 |
68%
upside
| Buy | 10 months ago |
|
14
Waters Corp
WAT
$17.8B
| $299.69 | $410 |
37%
upside
| Hold | 10 months ago |
|
15
Danaher
DHR
$143B
| $199.03 | $315 |
58%
upside
| Buy | 10 months ago |
|
16
Agilent Technologies
A
$36.4B
| $128.48 | $160 |
25%
upside
| Buy | 1 year ago |
|
|
17
Guardant Health
GH
$7.65B
| $61.36 | $42 |
32%
downside
| Buy | 1 year ago |
|
18
Myriad Genetics
MYGN
$632M
| $6.79 | $30 |
342%
upside
| Hold | 1 year ago |
|
19
Avantor
AVTR
$8.99B
| $13.19 | $31 |
135%
upside
| Buy | 1 year ago |
|
20
Thermo Fisher Scientific
TMO
$185B
| $489.49 | $658 |
34%
upside
| Buy | 1 year ago |
|
21
Verizon
VZ
$186B
| $44.18 | $51 |
15%
upside
| Buy | 1 year ago |
|
22
NeoGenomics
NEO
$1.04B
| $8.06 | $20 |
148%
upside
| Buy | 1 year ago |
|
23
10x Genomics
TXG
$1.69B
| $13.57 | $32 |
136%
upside
| Hold | 1 year ago |
|
24
lululemon athletica
LULU
$24.7B
| $206.09 | $546 |
165%
upside
| Outperform | 1 year ago |
|
25
Pacific Biosciences
PACB
$372M
| $1.24 | $15 |
1,110%
upside
| Outperform | 2 years ago |
|